Lipoprotein(a) and ApoB Explained: The Cholesterol Markers a Standard Test Misses

What a standard cholesterol test actually measures

When most people say "cholesterol test," they mean a standard lipid panel. It checks four numbers:

• LDL cholesterol, often called "bad" cholesterol
• HDL cholesterol, often called "good" cholesterol
• Triglycerides, tied to diet, weight and metabolic health
• Total cholesterol, roughly the sum carried across these particles

Alongside blood pressure, age, smoking and family history, these numbers feed the risk calculators doctors use. For most people, that does a reasonable job.

What the standard panel does not do is count particles, or check inherited risk factors outside those four numbers. Two people can have the same LDL result and a different underlying risk. That is the gap lipoprotein(a) and ApoB testing fills.

What is lipoprotein(a)

Lipoprotein(a), or Lp(a), pronounced "L-P-little-a," is an LDL-like particle with an extra protein attached. That protein is thought to promote plaque build-up and blood clotting.

Elevated levels are linked to a higher risk of heart attack, stroke and aortic valve disease, separate from your other cholesterol numbers.

• It is set by your genes. Diet, exercise and weight loss do not meaningfully change it.
• You usually only test it once. It stays roughly stable through adult life (Pathology Tests Explained).
• About 1 in 5 people are thought to have an elevated level, and it has never been part of a routine lipid panel.

What is ApoB

Apolipoprotein B (ApoB) is the main protein on LDL, VLDL and other "bad" cholesterol-carrying particles. Every one of these particles carries exactly one ApoB.

So measuring ApoB gives a direct count of potentially artery-clogging particles. LDL cholesterol only tells you how much cholesterol those particles carry.

The two can disagree, especially with insulin resistance, type 2 diabetes, obesity or high triglycerides. In those cases, ApoB can flag a risk that LDL cholesterol understates.

Why particle count can tell a different story to cholesterol content

Doctors call this "discordance." Here is what it looks like with the same LDL cholesterol result:

Same LDL cholesterol number. Person B has more particles.

Each particle can enter the artery wall and contribute to plaque, so Person B carries more risk. ApoB shows the difference because it counts particles directly.

It is also part of why some people have a heart attack despite an LDL result their doctor considered acceptable. The LDL result was not wrong. It just was not measuring what mattered most for that person.

Who might consider testing lipoprotein(a) and ApoB

These are not routine tests for everyone. They add the most value if you have:

• A family history of early heart attack or stroke, in a parent or sibling before 55 for men or 65 for women
• High cholesterol that runs in the family (familial hypercholesterolaemia)
• A heart event or diagnosis younger than expected, or despite a normal LDL result
• Type 2 diabetes, insulin resistance or metabolic syndrome
• A wish for a fuller picture before long-term heart health decisions with your doctor

Because Lp(a) is inherited, some people test after a close relative is found to have a high level.

Reference ranges and units

Check which unit your result uses before comparing it with anything online.

The two Lp(a) units do not convert with a simple formula, because Lp(a) particles vary in size between people. Reference ranges also vary by laboratory, so always compare your result with the range printed on your own report.

How lipoprotein(a) and ApoB fit into the bigger picture

Both are most useful read alongside the rest of your heart and metabolic health. You can test them on their own or as part of a wider panel:

What happens after your result comes back

Your report compares your Lp(a) and ApoB results with the laboratory's reference range and flags anything outside it. What you do next is up to you.

Lp(a) does not change much with diet or exercise, so most people only need to test it once. ApoB responds to the same changes as LDL cholesterol, including diet and activity, so it can be worth rechecking over time.

Where ApoB and lipoprotein(a) fit alongside cholesterol-lowering treatment

ApoB: European cardiology guidelines recommend ApoB as a secondary target, particularly with diabetes, high triglycerides or metabolic syndrome. It shows whether particle numbers have actually come down, even when LDL looks well controlled (ESC/EAS 2019).

Lipoprotein(a): statins and most standard cholesterol medicines do not meaningfully lower it. A high result usually shapes the wider risk conversation instead, such as how closely blood pressure, smoking and LDL are managed.

Treatments aimed specifically at lowering Lp(a) are being researched, but are not yet part of routine care in Australia. An elevated result is one to discuss with a doctor.

Frequently asked questions